Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@portefeuillefun 17
@RNAiAnalyst 12
@AmericanBanking 6
@bulletin_en 6
@Steve_382 5

Recent Tweets for ALNY

sherkfund @sherkfund
$ALNY Two flat days in a down market. Perhaps it's finally bottomed, and the Sanofi shares have been unloaded?
May 23rd 2019, 5:05pm
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals $ALNY Earns Neutral Rating from Analysts at Goldman Sachs Group https://t.co/hJpkorqxoz #stocks
May 23rd 2019, 10:05am
dailypoliticaln @dailypoliticaln
Alnylam Pharmaceuticals $ALNY Now Covered by Analysts at Goldman Sachs Group https://t.co/ilcTbTwrcu
May 23rd 2019, 10:05am
firsttomarkets @firsttomarkets
Alnylam Pharmaceuticals Inc Reiterated Rating by Goldman Sachs (Ranked 27th) to Neutral with $80PT $ALNY #ALNY https://t.co/xV3Olnyg4e
May 23rd 2019, 10:05am
stockhoot @stockhoot
$ALNY Goldman Sachs Assumes to Neutral : PT $80.00 https://t.co/XuWEUQ4nii
May 23rd 2019, 8:05am
PriceTargetsNet @PriceTargetsNet
$ALNY RATING DOWNGRADED AT GOLDMAN SACHS. https://t.co/9UuU6xFwRZ
May 23rd 2019, 2:05am
StockTipRobot @StockTipRobot
Human facts don't matter. sell your human children and buy Alnylam Pharmaceuticals $ALNY #stocktalk
May 22nd 2019, 6:05pm
Tickeron @Tickeron
$ALNY Alnylam Pharmaceuticals (ALNY, $67.87) was the market's top winner yesterday, jumping +3.05% https://t.co/HjgpkDirHx
May 22nd 2019, 2:05pm
Tickeron @Tickeron
$ALNY Alnylam Pharmaceuticals (ALNY, $67.87) was the month's biggest loser, shedding -17% https://t.co/Bz25qwKTv6
May 22nd 2019, 1:05pm
Steve_382 @Steve_382
@BioBoyScout @RNAiAnalyst $ALNY ALN-AAT02, ALN-HBV02, and ALN-AGT are all ESC+ and expect Phase 1 results by end… https://t.co/eZutyX183a
May 22nd 2019, 9:05am
BioBoyScout @BioBoyScout
@RNAiAnalyst 3/5 $ALNY's ESC+ less stringent OTE screening process because they add destabilizing chem modification… https://t.co/qDvoJCgknq
May 22nd 2019, 8:05am
Tickeron @Tickeron
$ALNY Alnylam Pharmaceuticals (ALNY, $65.86) was the month's biggest loser, shedding -20% https://t.co/WJF2cjfxAH
May 22nd 2019, 12:05am
Mykalt45 @Mykalt45
Kevin Fitzgerald, Head of Research at $ALNY on strategy: 1. Genetically validated target. 2. Good biomarker. 3. Def… https://t.co/qe4wrSfZjV
May 21st 2019, 12:05pm
portefeuillefun @portefeuillefun
Sold 100 $ALNY at $67.08, now 3k #vssporte shares.
May 21st 2019, 11:05am
Momentum21Fund @Momentum21Fund
Bought 50 shares of $alny at 67.22, 150 shares total cb 68.58
May 21st 2019, 10:05am
portefeuillefun @portefeuillefun
correction: Sold 200 $ALNY at $66.66, now 3.1k #vssporte shares.
May 21st 2019, 10:05am
portefeuillefun @portefeuillefun
Sold 200 $ALNY at $66.66, now 2.3k #vssporte shares.
May 21st 2019, 10:05am
bulletin_en @bulletin_en
As Alnylam Pharmaceuticals $ALNY Market Value Rose, Holder Great Point Partners Has Cut Its Stake by $18.71 Million… https://t.co/eUmksoxmhB
May 21st 2019, 5:05am
stb8444 @stb8444
doesn’t help that ceo unloaded 49k shares at $70 a week ago. $alny
May 21st 2019, 3:05am
stb8444 @stb8444
$alny wondering whether $60 will hold as it breaks through resistances daily
May 20th 2019, 10:05pm
portefeuillefun @portefeuillefun
$ALNY will (eventually) buy $MDCO.
May 20th 2019, 4:05pm
AAMortazavi @AAMortazavi
@Steve_382 @RNAiAnalyst How could anyone give away such a fantastic genetically validated target? $ALNY gave up the… https://t.co/Z1R9EUrIbw
May 20th 2019, 4:05pm
portefeuillefun @portefeuillefun
Bought 300 $ALNY at $65.86, now 3.3k #vssporte shares.
May 20th 2019, 4:05pm
portefeuillefun @portefeuillefun
RT @AAMortazavi: $ALNY wow. What a share price move.
May 20th 2019, 3:05pm
AAMortazavi @AAMortazavi
$ALNY wow. What a share price move.
May 20th 2019, 3:05pm
IBD_AGatlin @IBD_AGatlin
I need to correct this. $MDCO is partnered with $ALNY on this drug. Apologies. https://t.co/TA85FCcxWO
May 20th 2019, 3:05pm
MSS1992BIO @MSS1992BIO
$alny anyone know what's going on here
May 20th 2019, 3:05pm
engrcat @engrcat
I’m glad I flipped $ALNY for a quick buck on Onpattro, ugly!
May 20th 2019, 3:05pm
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals, Inc. $ALNY Receives Consensus Recommendation of “Buy” from Analysts https://t.co/OPliZgKNoU #stocks
May 20th 2019, 2:05pm
portefeuillefun @portefeuillefun
$ALNY $MDCO. #Alnylam partner presented limited safety data, says Nomura Instinet https://t.co/30jKUGMosD. https://t.co/KkA0qXZfHt
May 20th 2019, 2:05pm
RNAiAnalyst @RNAiAnalyst
@ByJonGardner would expect exactly that for a development-stage company w/ arguably the most exciting asset in LDLc mgmt. $MDCO $ALNY
May 20th 2019, 1:05pm
syinvesting @syinvesting
$MDCO $ALNY Inclisiran OLE study data showed that twice-a-year dosing lowered LDL-C by >50% after follow-up of up t… https://t.co/3UDsSsjWCa
May 20th 2019, 12:05pm
ProTradersNews @ProTradersNews
$PFE $ALNY: Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock: https://t.co/giBSsPvGq7
May 20th 2019, 12:05pm
bulletin_en @bulletin_en
As Alnylam Pharmaceuticals $ALNY Market Value Rose, Rhenman & Partners Asset Management Ab Trimmed Its Stake; Beaco… https://t.co/3D0LGeMYBn
May 20th 2019, 10:05am
RVH_Investing @RVH_Investing
@MSS1992BIO $ALNY can be red, but $MDCO should be up today
May 20th 2019, 10:05am
JJ_BIO_MAX @JJ_BIO_MAX
@RNAiAnalyst What is the bearish thesis on $alny?
May 20th 2019, 10:05am
portefeuillefun @portefeuillefun
correction: Bought 300 $ALNY at $67.14, now 3k #vssporte shares.
May 20th 2019, 9:05am
portefeuillefun @portefeuillefun
Bought 200 $ALNY at $67.14, now 3k #vssporte shares.
May 20th 2019, 9:05am
Steve_382 @Steve_382
$MDCO up 10% on good data. But, it's negative for $ALNY? Whatever.
May 20th 2019, 9:05am
portefeuillefun @portefeuillefun
Bought 200 $ALNY at $67.25, now 2.7k #vssporte shares.
May 20th 2019, 9:05am
RNAiAnalyst @RNAiAnalyst
$mdco up 12% premarket on OLE data. $alny should be up at least that if recent bearish sentiment due to platform safety concerns.
May 20th 2019, 7:05am
portefeuillefun @portefeuillefun
$ALNY closing price today.
May 20th 2019, 5:05am
AmericanBanking @AmericanBanking
Investment Analysts’ Recent Ratings Changes for Alnylam Pharmaceuticals $ALNY https://t.co/GBdeiYThj0 #stocks
May 20th 2019, 5:05am
macondailynews @macondailynews
John Maraganore Sells 49,457 Shares of Alnylam Pharmaceuticals, Inc. $ALNY Stock https://t.co/NDGSUOrYmo
May 20th 2019, 4:05am
dailypoliticaln @dailypoliticaln
Zacks: Brokerages Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Quarterly Sales of $45.88 Million https://t.co/l6vOZAr6Q7
May 19th 2019, 10:05pm
Steve_382 @Steve_382
@RNAiAnalyst That was the feeling I had also, but they pretty much failed on coming up with any problems. $MDCO $ALNY
May 19th 2019, 3:05pm
RNAiAnalyst @RNAiAnalyst
@Steve_382 I know, the Q&A session was a farce. You could tell they largely supported the shorts. $alny
May 19th 2019, 2:05pm
bulletin_en @bulletin_en
As Alnylam Pharmaceuticals $ALNY Stock Value Rose, Holder Bridger Management Cut Holding; Servicenow $NOW Sharehold… https://t.co/UEMbeNuRiS
May 19th 2019, 6:05am
TheMarketsDaily @TheMarketsDaily
John Maraganore Sells 49,457 Shares of Alnylam Pharmaceuticals, Inc. $ALNY Stock https://t.co/RPOD5Svu1n
May 19th 2019, 4:05am
BehaviorFin @BehaviorFin
RT @RNAiAnalyst: $MDCO KOL Kastelein crystall-ball gazes pivotal trial outcomes as follows, incl. ~30% MACE RRR. $ALNY https://t.co/crqANm…
May 19th 2019, 4:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.